Review article · 2025 · Open access

PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation

Endry Wahyu Syahputra, Hyunji Lee, Hyuk Jun Cho, Hyun Jin Park, Kwang‐Su Park, Duhyeong Hwang

Pharmaceutics, 17(4), 501 · Published 9 April 2025 · DOI 10.3390/pharmaceutics17040501

Open PDFView at the publisherCite this paper

In brief

“PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation” is a 2025 review article by Endry Wahyu Syahputra and 5 co-authors, published in Pharmaceutics. OpenAlex counts 91 citations as of 19 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Pharmaceutics.

Citations
91
Most cited in
2026 (69)
Field-weighted impact
6.30
References
116
Authors
6

Abstract

Proteolysis targeting chimeras (PROTACs), heterobifunctional molecules that hijack the ubiquitin-proteasome system (UPS) to degrade specific proteins, hold great promise in treating diseases driven by traditionally "undruggable" targets. However, their large molecular weight, high hydrophobicity, and other physicochemical hurdles contribute to their limited bioavailability, suboptimal pharmacokinetics, and attenuated therapeutic efficacy. Consequently, diverse formulation innovations have been investigated to optimize PROTAC delivery. This review examines current challenges and advances in specialized drug delivery approaches designed to bolster PROTAC pharmacological performance. We first outline the fundamental limitations of PROTACs-their low aqueous solubility, poor cell permeability, rapid clearance, and concentration-dependent "hook effect". We then discuss how various enabling formulations address these issues, including polymeric micelles, emulsions, amorphous solid dispersions, lipid-based nanoparticles, liposomes, and exosomes. Collectively, these delivery technologies substantially improve the therapeutic outcomes of PROTACs in preclinical cancer models. Future applications may extend beyond oncology to address other complex diseases using newly emerging heterobifunctional molecules. By integrating advanced formulation science with innovative degrader design, the field stands poised to unlock the clinical potential of PROTACs for protein degradation therapies.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Syahputra, E. W., Lee, H., Cho, H. J., Park, H. J., Park, K., & Hwang, D. (2025). PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation. Pharmaceutics, 17(4), 501. https://doi.org/10.3390/pharmaceutics17040501

MLA 9

Syahputra, Endry Wahyu, et al. “PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation.” Pharmaceutics, vol. 17, no. 4, 2025, p. 501. https://doi.org/10.3390/pharmaceutics17040501.

Chicago

Syahputra, Endry Wahyu, Hyunji Lee, Hyuk Jun Cho, Hyun Jin Park, Kwang‐Su Park, and Duhyeong Hwang. 2025. “PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation.” Pharmaceutics 17 (4): 501. https://doi.org/10.3390/pharmaceutics17040501.

Harvard

Syahputra, E. W. et al. (2025) ‘PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation’, Pharmaceutics, 17(4), p. 501. doi:10.3390/pharmaceutics17040501.

IEEE

E. W. Syahputra, H. Lee, H. J. Cho, H. J. Park, K. Park, and D. Hwang, “PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation,” Pharmaceutics, vol. 17, no. 4, p. 501, 2025, doi: 10.3390/pharmaceutics17040501.

BibTeX

@article{syahputra2025protac,
  title     = {{PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation}},
  author    = {Syahputra, Endry Wahyu and Lee, Hyunji and Cho, Hyuk Jun and Park, Hyun Jin and Park, Kwang‐Su and Hwang, Duhyeong},
  journal   = {Pharmaceutics},
  year      = {2025},
  volume    = {17},
  number    = {4},
  pages     = {501},
  doi       = {10.3390/pharmaceutics17040501},
  url       = {https://doi.org/10.3390/pharmaceutics17040501}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors

  • PROTACs
  • targeted protein degradation
  • drug delivery
  • drug formulation
  • pharmacokinetics
  • bioavailability
  • hook effect
  • polymeric micelles

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Syahputra, E. W., Lee, H., Cho, H. J., Park, H. J., Park, K., & Hwang, D. (2025). PROTAC Delivery Strategies for Overcoming Physicochemical Properties and Physiological Barriers in Targeted Protein Degradation. Pharmaceutics, 17(4), 501. https://doi.org/10.3390/pharmaceutics17040501

How many times has this paper been cited?

91 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Pharmaceutics: sign in and open the PDF from this page.

Who wrote this paper?

Endry Wahyu Syahputra, Hyunji Lee, Hyuk Jun Cho, Hyun Jin Park, Kwang‐Su Park, Duhyeong Hwang.

What is the DOI of this paper?

10.3390/pharmaceutics17040501, permanently at https://doi.org/10.3390/pharmaceutics17040501. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.